Patients treated for rectal cancer at hospitals that are accredited by the American College of Surgeons (ACS) National Accreditation Program for Rectal Cancer (NAPRC) were less likely to have cancer left behind after surgery, a major factor for recurrence, according to a new study published in the Journal of the American College of Surgeons. The findings reinforce that where patients receive care can significantly influence their outcomes.